Abstract
Background. There are limited data regarding clinical presentation and management of Staphylococcus aureus central line-associated bloodstream infection (CLABSI) in immunocompromised cancer patients. Methods. In this review, we evaluated 299 patients with 304 episodes of S. aureus-CLABSI between 2005 and 2011. Findings. By multivariate analysis, the major predictors of complicated S. aureus-CLABSI were septic shock, catheter site inflammation, presence of peripherally inserted central catheter, anti-cancer chemotherapy within 10 days, and persistent bacteremia beyond 72 hours (P ≤ 0.02). A total of 67% of the cases were defined as complicated. In the subset of patients who were uncomplicated on presentation, patients receiving antimicrobials ≥ 14 days had similar rates of relapse, attributable mortality, and development of complications compared to those receiving shorter-course therapy. By competing risk analysis, removal of the catheter within 3 days of the onset of bacteremia was associated with a lower relapse rate at 90 days (P = 0.024). Interpretation. The majority of S. aureus-CLABSI in cancer patients are complicated and require prolonged course of antimicrobial treatment. Early removal of the catheter within the first 3 days is associated with better course. In patients with prompt removal of the catheter and no evidence of a complicated course, treatment beyond 2 weeks may not be necessary.
Original language | English (US) |
---|---|
Pages (from-to) | 163-168 |
Number of pages | 6 |
Journal | Annals of Medicine |
Volume | 46 |
Issue number | 3 |
DOIs | |
State | Published - May 2014 |
Keywords
- CLABSI
- Cancer
- Complications
- Management
- Staphylococcus aureus
ASJC Scopus subject areas
- General Medicine